-- Abbott's Alinity™ m Resp-4-Plex assay will allow healthcare workers to test for four viruses in one test, a critically important tool as flu presents with similar symptoms -- The test helps save on ...

(RTTNews) - Abbott (ABT) has received FDA clearance for its Alinity m STI Assay test, which simultaneously detects and differentiates four common sexually transmitted infections. The Alinity m STI ...

Abbott Laboratories is adding HPV screening to its "Alinity m" family of diagnostic assays following U.S. Food & Drug Administration approval. Abbott said in a press release that the FDA approved its ...

According to the U.S. Centers for Disease Control (CDC), most sexually active adults will experience HPV infections; new test detects those HPV genotypes that could lead to cancer Abbott (ABT)'s new ...

The World Health Organization (WHO) estimates that more than 1 million individuals contract a sexually transmitted infection (STI) every day. The most common STI pathogens are Chlamydia trachomatis ...

More than 250 HPV tests and hundreds of different variants are commercially available globally, but majority of these tests do not meet the performance characteristic standards agreed upon in the HPV ...

The FDA urged clinical laboratories and healthcare providers to retest any patients who have recently received a positive result from two of Abbott’s PCR COVID-19 assays after identifying a heightened ...

The World Health Organization (WHO) has listed the first mpox in vitro diagnostic (IVD) under its Emergency Use Listing (EUL) procedure, an important step in improving global access to mpox testing.

Abbott has received US Food and Drug Administration (FDA) approval for its molecular human papillomavirus or HPV screening solution, adding a powerful cancer screening tool for detecting high-risk HPV ...